Skip to content

Clinical trials

Giant Cell Arteritis trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Giant Cell Arteritis Country / region: Canada Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20061
20081
20101
20111
20131
20161
20171
20181
20193
20202
20212
20221
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Recruiting5
Terminated2
Not yet recruiting1
Active, not recruiting1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Pennsylvania6
Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal3
AbbVie1
Bristol-Myers Squibb1
Hoffmann-La Roche1
Janssen Research & Development, LLC1
Jewish General Hospital1
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)1
Novartis Pharmaceuticals1
Sanofi1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Giant Cell Arteritis20
Takayasu Arteritis5
Vasculitis5
Churg-Strauss Syndrome4
Granulomatosis with Polyangiitis4
Microscopic Polyangiitis4
Polyarteritis Nodosa4
Arteritis2
Disease2
Aortitis1

Trials

Showing 51 to 20 of 20. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.